Drug Discovery

1 article

Reid Hoffman, co-founder of LinkedIn, leaving Microsoft's corporate environment to embrace the future of AI drug discovery startups.

Venture & Funding

Reid Hoffman to leave Microsoft board for AI startup

After years advising one of the world's most powerful tech companies, Reid Hoffman plans to leave Microsoft's board.

Sameh El-Masry·June 6, 2026